Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
A truck has collided with a tram in Nice this morning. The accident, on Line 1 of the tramway on Avenue Jean Medecin, happened at about 9.30am...
Read More
A woman in her early thirties has been killed after being hit by a car while walking on the A570 motorway near La Crau in the Var. The incident occurr...
Read More
Ceremonies have been taking place in Paris to commemorate the tenth anniversary of the attacks of 13 November 2015. 132 people lost their lives and ov...
Read More
France’s parliament is continuing to debate the draft 2026 national budget, and several measures under discussion could have a direct impact on foreig...
Read More
A man is in a critical condition in hospital after being found with wounds to his throat in Nice
Read More
